Active Pharmaceutical Ingredient

Sterling expects further HPAPI demand, looks for buy-out opportunities

15-Jan-2020 By Vassia Barba

Sterling continues expansion and lines up further acquisitions, as the HPAPI market continues to see increasing demand, a company executive says.

Almac granted $1m to develop low-cost API manufacturing method

09-Dec-2019 By Vassia Barba

Under funding from Bill and Melinda Gates Foundation, Almac initiates work to develop biosynthetic routes for APIs to be used in world aid programs.

Heraeus adds ‘much-needed’ capacity for chemo components manufacture

25-Nov-2019 By Vassia Barba

Heraeus adds production line to expand its capacity for the manufacture of platinum-based HPAPIs.

Provepharm builds plant to cover its own APIs supply needs

30-Sep-2019 By Vassia Barba

Provepharm expands its facilities in order to manufacture its own active pharmaceutical ingredients, which will be used for molecule revitalization.

LGM expands its services for section 503B APIs

15-Jul-2019 By Vassia Barba

LGM expands its service offerings to further support companies that supply APIs to compounding pharmacies under the FDA’s 503B section.

Piramal expands high potency API facility in Michigan

27-Jun-2019 By Vassia Barba

Piramal’s $10m expansion at its site in Michigan supports ‘dramatic growth’ and ‘brings more to the table’.

Lonza ups HPAPI encapsulation capacity in Florida

22-Feb-2018 By Staff Reporter

Lonza has increased its encapsulation capacity and invested in highly potent active pharmaceutical ingredient (HPAPI) services at a facility in Tampa, Florida.

Pfizer pulls batches of antibiotic in Australia over anaphylaxis risk

19-Oct-2017 By Gareth Macdonald

Pfizer has recalled 10 batches of gentamicin in Australia because of problems with an API supplied by a third party.

Update

Piramal boosts HPAPI site in Michigan, US

11-Oct-2017 By Flora Southey

Piramal Pharma Solutions will expand its high potency active pharmaceutical ingredient (HPAPI) capabilities at its Riverview site in Michigan, US.

AkzoNobel ups pharma salt capacity in Denmark

10-Oct-2017 By Dan Stanton

AkzoNobel has expanded a facility in Denmark on the back of high demand for pharmaceutical grade salt.

Merck & Co API operations hit by cyberattack yet to restart production

31-Jul-2017 By Gareth Macdonald

API operations hit by the Petya cyberattack have not been restored according to Merck & Co Inc, which expects difficulties fulfilling some product orders and lower 2017 profits partly due to the hack. 

WHO prequalifies Mylan's India unit to supply TB drug API

20-Jul-2017 By Gareth Macdonald

The WHO has prequalified Indian-based Mylan Laboratories Ltd to supply the tuberculosis drug ingredient protionamide.

Tetraphase hires Patheon to make its synthetic antibiotic eravacycline

22-Jun-2017 By Gareth Macdonald

Tetraphase Pharmaceutical has hired Patheon UK Limited to make and test the synthetic antibiotic eravacycline.

US FDA rejects Sun epilepsy drug due to ongoing problems at Halol plant

24-May-2017 By Gareth Macdonald

The US FDA has refused to reapprove Sun Pharma Advanced Research LTD’s epilepsy drug Elepsia XR (levetiracetam) citing problems at its plant in Halol, India.

The hunt for work after red October: Novo cites military experience as a big plus

02-Sep-2015 By Gareth Macdonald

Novo Nordisk says nuclear submarine veterans’ “mission critical” mentality is suited to pharmaceutical manufacturing environment.